About Proteon Pharmaceuticals
Proteon Pharmaceuticals is a company based in Łodz (Poland) founded in 2005 by Jarosław Dastych.. Proteon Pharmaceuticals has raised $28.79 million across 2 funding rounds from investors including Nutreco, Aqua Spark and Montis Capital. The company has 14 employees as of April 10, 2024. Proteon Pharmaceuticals offers products and services including BAFACOL, BAFADOR, BAFASAL, and BAFASAL + G. Proteon Pharmaceuticals operates in a competitive market with competitors including Zoetis, Ceva, Embark Veterinary, AnimalBiome and Hendrix Genetics, among others.
- Headquarter Łodz, Poland
- Employees 14 as on 10 Apr, 2024
- Founders Jarosław Dastych
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Proteon Pharmaceuticals India Private Limited
- Date of Incorporation 27 Dec, 2017
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$386.32 K (USD)-20.21as on Mar 31, 2022
-
Net Profit
$-465.01 K (USD)-66.23as on Mar 31, 2022
-
EBITDA
$-451.22 K (USD)-91.41as on Mar 31, 2022
-
Total Equity Funding
$28.79 M (USD)
in 2 rounds
-
Latest Funding Round
$24.68 M (USD), Series B
Aug 10, 2021
-
Investors
Nutreco
& 3 more
-
Employee Count
14
as on Apr 10, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Proteon Pharmaceuticals
Proteon Pharmaceuticals offers a comprehensive portfolio of products and services, including BAFACOL, BAFADOR, BAFASAL, and BAFASAL + G. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Phage product for improving gut health in poultry.
Solution for antimicrobial resistance in livestock.
Targets food-borne pathogens like Salmonella for safety.
Enhanced phage product for gut health and resistance.
Unlock access to complete
Funding Insights of Proteon Pharmaceuticals
Proteon Pharmaceuticals has successfully raised a total of $28.79M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $24.68 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $24.7M
-
First Round
First Round
(24 Oct 2017)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2021 | Amount | Series B - Proteon Pharmaceuticals | Valuation | Nutreco | |
| Oct, 2017 | Amount | Series A - Proteon Pharmaceuticals | Valuation | Aqua Spark |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Proteon Pharmaceuticals
Proteon Pharmaceuticals has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Nutreco, Aqua Spark and Montis Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on aquaculture sectors
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided by Montis Capital.
|
Founded Year | Domain | Location | |
|
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Proteon Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Proteon Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Proteon Pharmaceuticals Comparisons
Competitors of Proteon Pharmaceuticals
Proteon Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Embark Veterinary, AnimalBiome and Hendrix Genetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| domain | founded_year | HQ Location |
Proivder of DNA test kits for dogs that enable dog owners to provide better pet care
|
|
| domain | founded_year | HQ Location |
Animal microbiome diagnostics services for pet care are offered.
|
|
| domain | founded_year | HQ Location |
Hybrid animal varieties are developed through marker-assisted breeding methods.
|
|
| domain | founded_year | HQ Location |
Provider of genetic testing for cats
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Proteon Pharmaceuticals
Frequently Asked Questions about Proteon Pharmaceuticals
When was Proteon Pharmaceuticals founded?
Proteon Pharmaceuticals was founded in 2005 and raised its 1st funding round 12 years after it was founded.
Where is Proteon Pharmaceuticals located?
Proteon Pharmaceuticals is headquartered in Łodz, Poland. It is registered at Łodz, Łodz Voivodeship, Poland.
Who is the current CEO of Proteon Pharmaceuticals?
Jarosław Dastych is the current CEO of Proteon Pharmaceuticals. They have also founded this company.
Is Proteon Pharmaceuticals a funded company?
Proteon Pharmaceuticals is a funded company, having raised a total of $28.79M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.11M, raised on Oct 24, 2017.
How many employees does Proteon Pharmaceuticals have?
As of Apr 10, 2024, the latest employee count at Proteon Pharmaceuticals is 14.
What is the annual revenue of Proteon Pharmaceuticals?
Annual revenue of Proteon Pharmaceuticals is $386.32K as on Mar 31, 2022.
What does Proteon Pharmaceuticals do?
Founded in 2005 and based in Lodz, Poland, the company operates in the animal health sector. Therapeutics targeting infectious diseases are developed using a proprietary bacteriophage platform, supported by expertise in microbiology, DNA sequencing, and bioinformatics. Solutions provided include a bacteriophage treatment for Salmonella in poultry and BAFADOR, which addresses Pseudomonas and Aeromonas infections in aquaculture operations.
Who are the top competitors of Proteon Pharmaceuticals?
Proteon Pharmaceuticals's top competitors include Zoetis, Ceva and Embark Veterinary.
What products or services does Proteon Pharmaceuticals offer?
Proteon Pharmaceuticals offers BAFACOL, BAFADOR, BAFASAL, and BAFASAL + G.
Who are Proteon Pharmaceuticals's investors?
Proteon Pharmaceuticals has 4 investors. Key investors include Nutreco, Aqua Spark, Montis Capital, and Seventure Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.